Coeptis Therapeutics COEP Holds Steady at 164 as Consolidation Phase Unfolds Golds Fragile Recovery Faces Headwinds from Rising Yields DRD Q3 2014 Earnings Surprise EPS Beat Amid Challenging Environment 67 Million Children Missing Out on Trump Account Benefits BKSY Q1 2026 Earnings Wide Earnings Miss as Revenue Not Disclosed Stock Declines VOYG Q1 2026 Earnings EPS Misses Estimates Stock Falls Over 4 RFL Q1 2025 Earnings Widening Losses Amid Continued Development Stage VIVS Q3 2025 Earnings EPS Surprises to the Upside Amid Operational Focus JCTC Q3 2025 Earnings Loss Reported Stock Surges 1435 Marsh MRSH Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady VYNE Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage